Skip to main content
Clinical Trials/JPRN-UMIN000039682
JPRN-UMIN000039682Not yet recruiting未知

Development of novel allo- or tumor-reactive T cell analyzing assay and exploring novel approach to manipulate T cell response - Development of novel allo- or tumor-reactive T cell analyzing assay and exploring novel approach to manipulate T cell response

Hiroshima University0 sites50 target enrollmentStarted: March 4, 2020Last updated:
Conditions

Trial Snapshot

Phase
未知
Status
Not yet recruiting
Enrollment
50

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Observational

Eligibility Criteria

Ages
20years-old to 50years-old (—)
Sex
All

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • 1, The person with regular hospital visit 2, THe person who have a axiuos about thier health. 3, The person with weight less than 40kg. 4, the person who did blood donation within 1 month. 5, The person possibly be pregnant. 6, The person has a history of infectious disease within a week. 7, The person who has a direct interst with the investigators, like teacher and student. 8, The person who is recognized as inappropriate for the candidate by investigators.

Investigators

Similar Trials

Study for regulating reactive T cells... | Clinical Trial